Company |
Drug |
Indication |
Allergan plc (Dublin) |
Aczone |
Acne |
Amag Pharmaceuticals Inc. (Waltham, Mass.) |
Makena |
To reduce the risk of preterm birth |
Bristol-Myers Squibb Co. (New York) |
Daklinza |
Chronic hepatitis C virus with HIV-1 co-infection |
Dr. Reddy's Laboratories Ltd. (Hyderabad, India) |
Zembrace Symtouch |
Acute migraine episodes, with or without aura |
Dr. Reddy's Laboratories Ltd. (Hyderabad, India) |
Zenavod |
Inflammatory lesions of rosacea |
Genentech (unit of Roche AG; Basel, Switzerland) |
Gazyva |
Follicular lymphoma |
Gilead Sciences Inc. (Foster City, Calif.) |
Harvoni |
Chronic hepatitis C virus |
Kremers Urban Pharmaceuticals Inc. (subsidiary of Lannett Co. Inc.; Philadelphia) |
Temozolomide |
Cancer |
Lannett Co. Inc. (Philadelphia) |
Sumatriptan |
Migraine |
Merck & Co. Inc. (Kenilworth, N.J.) |
Emend |
To prevent delayed nausea and vomiting |
Merck & Co. Inc. (Kenilworth, N.J.) |
Zepatier |
Hepatitis C virus |
Novartis AG (Basel, Switzerland) |
Afinitor |
Progressive, well-differentiated, nonfunctional neuroendocrine tumors of gastrointestinal or lung origin that are unresectable, locally advanced or metastatic |
Optinose A/S (Oslo, Norway) and Avanir Pharmaceuticals Inc. (Aliso Viejo, Calif.) |
Onzetra Xsail |
Migraine with or without aura |
Pfizer Inc. (New York) |
Ibrance |
Metastatic breast cancer |
Pfizer Inc. (New York) |
Xeljanz XR |
Moderate to severe rheumatoid arthritis |
Promius Pharma LLC (Princeton, N.J.; subsidiary of Dr. Reddy's Laboratories Ltd.) |
Sernivo |
Mild to moderate plaque psoriasis |
UCB SA (Brussels, Belgium) |
Briviact |
Partial-onset seizures in epilepsy |